Filed in archive Drugs, Vaccines and Therapeutics by ruth on December 23, 2005

FDA grants orphan drug designation to Adherex Technologies' lead candidate, Eniluracil, which has been designed to improve the effectiveness of fluoropyrimidines or 5-FU in liver cancer chemotherapy. Eniluracil, inhibits the 5-FU breakdown, and thereby increase its effectiveness. Additionally, it reduces its side effects and makes it orally available. However there have been drawbacks identified, and Adherex plans to repeat clinical trials. according to an article at the Triangle Business Journal,

Durham-based Adherex announced in November that it had received approval from the FDA to begin clinical trials of the drug - just months after sealing a drug-exchange deal with GlaxoSmithKline for development rights.
Under the agreement, Glaxo could buy back the drug at a later date, in which case Adherex would be eligible to receive up to $120 million in development and sales milestone payments, plus royalties.

Read more from the Adherex press release, or more on liver cancer from Elsevier and from the National Cancer Institute.

Related Entries:

mTOR Inhibitor Designated as Orphan Drug - 23 August 2005
Oligonucleotide Therapeutics Society Symposium on Oligonucle... - 26 August 2005
Anticancer Drug Against Hodgkin's and Leukemia Granted Orpha... - 31 January 2006
CSL Limited Enters Flu Vaccine Market - 07 February 2006
Corn Clothes: The New Fashion - 25 April 2006
Diabetes Drug Avandia® (rosiglitazone maleate) Boosts Potenc... - 09 May 2007
Tuberculosis Drug Candidate SQ109 Granted Orphan Drug Status - 30 October 2007
Chemotherapy Drug Triggers Fatal Allergic Reactions - 09 June 2009

« Acologix Secures $24.3M i... | Main | Using Stem Cells To Treat... »

Permalink: Eniluracil Granted Orphan Drug Status

Tags: chemotherapy liver biotech drug eniluracil orphan+drug eniluracil+granted drug+status

Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/12790

Addthis

Ask

Blinklist

del.icio.us

Digg

Fark

Facebook

Google

Lycos

Ma.gnolia

Mr Wong

Netscape

Netvousz

Newsvine

StumbleUpon

Slashdot

Tailrank

Technorati

Wink

Yahoo

Vote for Eniluracil Granted Orphan Drug Status:

Currently 6.00/10
1
2
3
4
5
6
7
8
9
10

Rating: 6.00 out of 1 vote(s) cast.

Add your response to Eniluracil Granted Orphan Drug Status:

Name: *

Email: (will never be shown)*

URL:

(* marked fields are required)

Notify me if more comments appear?

Subscribe to The Biotech Weblog newsletter? (Newsletters are sent out weekly).

Remember me

Security Code: *
(Please help us to sort out spam.)

Please enter your comment here: (Sorry, no HTML is allowed - URLs will be made clickable automatically if you add http:// to your URL.)

We welcome your comments, however all comments are moderated. Offensive or off-topic comments will be deleted and not displayed.

Share It

Use the search to look for other interesting posts

Contributors (Last 90 days)

Shawn Hessinger (1)
Gloria Gamat (5)
Ruth Schaffer (14)
Creative Weblogging (3)

This site has 1333 entries and is powered by Creative Weblogging since July 2005.

Our Editors recommend

Disclaimer

Some of the contents of this site are protected Creative Weblogging Inc. 2004-2010.

Check out our Sponsored Blogs!

Business Computer Blog (UK)

Are you interested in writing a blog in our network?

See which positions are currently open.

Testimonials

'Very nice blog layout with great content. Are you interested in Star Trek props that are quickly becoming reality? Then this is the blog for you. Human medical scanners, nano technology and more great technological advancements.' -VirtualLoop Blog of the Week

'I subscribe to your blog and have been enjoying your posts and perspective.'